NCT04981418

Brief Summary

Evaluating the Management of chronic Pelvic girdle pain following Pregnancy (EMaPP) During pregnancy pelvic girdle pain is common. This pain will often reduce following childbirth, however almost 20% of women continue to suffer significant pain for at least three months afterwards. When pain is severe it will affect everyday activities and quality of life. Usual treatment typically involves Physiotherapy (advice and exercise) and provision of an "off the shelf" rigid pelvic support belt. Women often find these uncomfortable and difficult to use. A customised pelvic orthotic (referred to as pelvic support shorts) is an alternative that on initial testing has shown promising results in women with chronic pelvic girdle pain.This feasibility study aims to obtain the data and operational experience necessary to inform the conduct and finalise the design of a future large randomised controlled trial. The investigators will also gather women's views about the support shorts and the trial. It is vital to understand what treatments are beneficial to this group of women and this is the main driver for this National Institute of Health Research funded trial. Following screening and consent, 60 women aged \> 18 years, with severe, persistent post-partum pelvic girdle pain will be recruited into the trial. They will be randomised to receive either usual care (advice and exercise) or usual care and the customised pelvic support shorts. All women will receive 2 web-based sessions with a physiotherapist who will provide this intervention. All will complete web-based self-report questionnaires (pain, function, quality of life, continence, depression) at baseline, 3 and 6 months. Fortnightly scoring of pain and medication usage throughout the trial timeline complements this. Fifteen women and five clinicians will be interviewed at the end of the trial to explore their experiences of wearing/providing the "support shorts" and participating in the trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

October 4, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2023

Completed
Last Updated

July 14, 2023

Status Verified

July 1, 2023

Enrollment Period

1.3 years

First QC Date

July 1, 2021

Last Update Submit

July 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline pain intensity (Numerical Rating Pain Scale) at 24 weeks

    Numerical pain rating scale. This is to assess pain levels across the course of the study period of 24 weeks. Women will be asked to rate their pain experience over the past fortnight, using the NPRS, in four categories: * Worst level of pelvic pain during the day * Average level of pelvic pain during the day * Worst level of pelvic pain during the night * Average level of pelvic pain during the night Scale runs between 0-10. Higher scores represent greater pain intensity.

    up to 24 weeks

Secondary Outcomes (7)

  • Pelvic girdle questionnaire

    Baseline, 12 weeks, 24 weeks

  • EQ-5D-5L

    Baseline, 12 weeks, 24 weeks

  • SF36

    Baseline, 12 weeks, 24 weeks

  • EPDS

    Baseline, 12 weeks, 24 weeks

  • iciq-ui sf

    Baseline, 12 weeks, 24 weeks

  • +2 more secondary outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

will receive standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat\_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource. The physiotherapist will teach participants a standardised programme of exercises, typical of those provided within usual physiotherapy practice. Written explanation/illustrations of these exercises will be provided and the women asked to undertake these at home, three times/week.

Other: ExerciseOther: advice

Intervention group

EXPERIMENTAL

In addition to the control groups intervention of exercise and advice, women in the intervention group will be fitted with the customised pelvic support shorts (DM Orthotics Ltd, https://www.dmorthotics.com). Prior to the first physiotherapy session, those women allocated to the intervention group will have recieved the support shorts in the post together with standardised written information on wear time/washing. At the first physiotherapy session (one hour), the woman will be asked to try them on so that the physiotherapist can review the fit and comfort of the shorts. The physiotherapist will reinforce the written advice about wear time and care of the shorts, and answer any queries / brainstorm any issues. At session two (30 minutes), \~10 days later, the physiotherapist will review the fit and wearing of the shorts, problem solve any issues that have arisen, and review exercises to ensure they are being performed correctly.

Device: customised pelvic support shortsOther: ExerciseOther: advice

Interventions

These apply targeted compressive forces to the pelvic girdle through selective precisely positioned reinforced lycra panels that aim to stabilize and align body segments to improve function and reduce unwanted movements. The construction material (Nylon and Elastane) is durable and breathable, and its mechanical properties enable it to provide "dynamic" stability and support (rather than the rigid support provided by "off-the-shelf" belts) during movement/functional activities. This aims to optimise comfort and movement to increase wear compliance, which is crucial as any benefits gained rely upon this.

Also known as: DEFO, ORTHOTIC
Intervention group

Women will be provided with up to a maximum of 4 exercises from a pre-defined list of exercises. Suggested dosages are referred to in the protocol. The exercise programme contains a range of exercise focused around the pelvic girdle and hips (including movement control and strengthening

Control groupIntervention group
adviceOTHER

standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat\_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource.

Control groupIntervention group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen only. This study is investigating pregnancy related pelvic girdle pain. The participants will need to have self reported PGP and therefore be female.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged greater than or equal to 18
  • Able and willing to provide informed consent
  • Self reported Persistent pelvic girdle pain (PGP) (≥3 months post partum)
  • Self reported severe PGP (causing walking or stair climbing to be bothersome)
  • Diagnosed with PGP in line with European guidelines
  • PGP must have started or been aggravated during pregnancy, as determined by self report

You may not qualify if:

  • known allergy to lycra
  • age \< 18
  • currently pregnant
  • PGP for \> 2 years post partum
  • Self reported history of pathologies causative of lumbo pelvic pain(e.g. Infection, trauma, cancer)
  • Participating in concurrent interventional research which may over-burden the patient or confound data collection
  • There are no special arrangements made for participants who are unable to adequately understand verbal and/or written English. There is no intention to exclude patients, therefore, if they have regular access to a friend or family member who is able to translate for them they would be able to participate
  • Participants who lack capacity to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Plymouth NHS Trust, Derriford Hospital

Plymouth, Devon, PL6 8DH, United Kingdom

Location

MeSH Terms

Conditions

Pelvic Girdle Pain

Interventions

Orthotic DevicesExerciseCounseling

Condition Hierarchy (Ancestors)

Musculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic Pain

Intervention Hierarchy (Ancestors)

Orthopedic EquipmentSurgical EquipmentEquipment and SuppliesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Jennifer Freeman, PhD

    University of Plymouth

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All outcomes measures are collected via self report means. This will enable the investigators to be blinded to the outcomes measures reported. Treating clinicians are also blinded to the outcome assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Teaching and research associate

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 29, 2021

Study Start

October 4, 2021

Primary Completion

February 4, 2023

Study Completion

February 4, 2023

Last Updated

July 14, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Access to the final trial dataset Data generated as a result of this trial will be available for inspection on request by the EMaPP research team, University of Plymouth representatives, the REC, local R\&D Departments and regulatory authorities

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
Academic paper to be written on completion of trial. Expected completion May 2022

Locations